RPC1063 would not be the names. it is a designation. some PR firm will get paid a lot of money to invent a grat selling name if the drug moves forward.
Unless the small company has gotten involved with another drug that is nowhere on their website, this has to be the drug.
I would ask the doc why you in particular are perfect for the trial. is it you specific symptoms/history, or just the fact that you came to his office the same week the drug company came?
they will also have to have an entry at trials.gov. I think this is it:www.clinicaltrials.gov/ct2/show/NCT01647516?term=RPC1063&rank=2
it says thee that you need moderate/severe UC to be included. You describe a hot spot and some recent symptoms, which sounds mild to me. Unless the doc had some evidence you current activity was more than mild, he seems to be hawking the study.
There is a chance you could get placebo. The three options are low dose, high dose, or placebo - and it runs for 32 weeks. That is a long time to go without other medication if you are just starting to flare.
I am not sure this is in your best interest.
Post Edited (DBwithUC) : 12/12/2012 8:16:38 AM (GMT-7)